You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
启明医疗(02500.HK)自主研发核心产品VenusA-Plus於中国获批上市
阿思达克 11-16 10:05
启明医疗(02500.HK)公布,公司自主研发的核心产品VenusA-Plus经导管人工主动脉瓣膜置换系统-可回收输送系统已获得中国国家药品监督管理局批准上市。VenusA-Plus的临床结果显示,其复合终点事件发生率低於预先设定的目标界值,显示出此产品良好的安全性、有效性和操控性。VenusA-Plus的上市将缩短临床医生的学习曲线,加快经导管主动脉瓣置换术在中国的发展普及。

启 明医疗将持续致力於结构性心脏病治疗性医疗器械的的研发和商业化,为患者提 供更为安全有效的临床解决方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account